Press Releases :: Ligand Pharmaceuticals Incorporated (LGND)

Press Releases

Ligand Reports Fourth Quarter and Full Year 2016 Financial Results

February 23, 2017

Dr. Christel Iffland Joins Ligand as Vice President, Antibody Technologies, Expands Team Focused on OmniAb Drug Discovery Platform

February 14, 2017

Reminder: Ligand to Host Analyst Day on February 28th in New York City

February 13, 2017

Ligand to Host Analyst Day on February 28th in New York City

January 24, 2017

Ligand to Report Fourth Quarter and Full Year 2016 Results on February 23rd

January 23, 2017

Ligand Enters Commercial License and Supply Agreements for Captisol®-enabled trametinib

December 22, 2016

Ligand Enters into Worldwide OmniAb® Platform License Agreement with ONO PHARMACEUTICAL CO., LTD.

December 22, 2016

Ligand Partner Retrophin Reports Additional Positive Data from Phase 2 DUET Study of Sparsentan in Focal Segmental Glomerulosclerosis at ASN Kidney Week 2016

November 21, 2016

Ligand Reports Third Quarter 2016 Financial Results

November 3, 2016

Ligand Partner Melinta Therapeutics Submits Baxdela New Drug Application for Hospital-Treated Skin Infections

October 24, 2016